Logo image of GRNB

VANECK GREEN BOND ETF (GRNB) Stock Price, Quote, News and Overview

NYSEARCA:GRNB - NYSE Arca - US92189F1710 - ETF - Currency: USD

23.947  +0.04 (+0.18%)

Fundamental Rating

6

Taking everything into account, GRNB scores 6 out of 10 in our fundamental rating. GRNB was compared to 83 industry peers in the Automobile Components industry. While GRNB belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. GRNB is valued quite cheap, but it does not seem to be growing. These ratings could make GRNB a good candidate for value investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

GRNB had positive earnings in the past year.
GRNB had a positive operating cash flow in the past year.
GRNB had positive earnings in each of the past 5 years.
Each year in the past 5 years GRNB had a positive operating cash flow.
GRNB Yearly Net Income VS EBIT VS OCF VS FCFGRNB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B 4B 5B

1.2 Ratios

With a decent Return On Assets value of 5.28%, GRNB is doing good in the industry, outperforming 72.29% of the companies in the same industry.
GRNB has a Return On Equity of 10.77%. This is in the better half of the industry: GRNB outperforms 71.08% of its industry peers.
GRNB has a better Return On Invested Capital (9.29%) than 71.08% of its industry peers.
GRNB had an Average Return On Invested Capital over the past 3 years of 9.16%. This is in line with the industry average of 9.58%.
The last Return On Invested Capital (9.29%) for GRNB is above the 3 year average (9.16%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.28%
ROE 10.77%
ROIC 9.29%
ROA(3y)5.54%
ROA(5y)4.82%
ROE(3y)11.67%
ROE(5y)10.63%
ROIC(3y)9.16%
ROIC(5y)8.51%
GRNB Yearly ROA, ROE, ROICGRNB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

With a decent Profit Margin value of 6.93%, GRNB is doing good in the industry, outperforming 75.90% of the companies in the same industry.
In the last couple of years the Profit Margin of GRNB has declined.
Looking at the Operating Margin, with a value of 12.44%, GRNB is in the better half of the industry, outperforming 78.31% of the companies in the same industry.
In the last couple of years the Operating Margin of GRNB has remained more or less at the same level.
GRNB's Gross Margin of 29.25% is fine compared to the rest of the industry. GRNB outperforms 69.88% of its industry peers.
In the last couple of years the Gross Margin of GRNB has remained more or less at the same level.
Industry RankSector Rank
OM 12.44%
PM (TTM) 6.93%
GM 29.25%
OM growth 3Y10.53%
OM growth 5Y-0.4%
PM growth 3Y31.62%
PM growth 5Y-1.53%
GM growth 3Y0.15%
GM growth 5Y-1.05%
GRNB Yearly Profit, Operating, Gross MarginsGRNB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

6

2. Health

2.1 Basic Checks

GRNB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, GRNB has about the same amount of shares outstanding.
The number of shares outstanding for GRNB has been reduced compared to 5 years ago.
GRNB has a better debt/assets ratio than last year.
GRNB Yearly Shares OutstandingGRNB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
GRNB Yearly Total Debt VS Total AssetsGRNB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B

2.2 Solvency

GRNB has an Altman-Z score of 2.43. This is not the best score and indicates that GRNB is in the grey zone with still only limited risk for bankruptcy at the moment.
GRNB has a Altman-Z score of 2.43. This is comparable to the rest of the industry: GRNB outperforms 51.81% of its industry peers.
GRNB has a debt to FCF ratio of 2.88. This is a good value and a sign of high solvency as GRNB would need 2.88 years to pay back of all of its debts.
GRNB's Debt to FCF ratio of 2.88 is fine compared to the rest of the industry. GRNB outperforms 75.90% of its industry peers.
A Debt/Equity ratio of 0.40 indicates that GRNB is not too dependend on debt financing.
GRNB's Debt to Equity ratio of 0.40 is fine compared to the rest of the industry. GRNB outperforms 62.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.88
Altman-Z 2.43
ROIC/WACC1.41
WACC6.6%
GRNB Yearly LT Debt VS Equity VS FCFGRNB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B 15B

2.3 Liquidity

GRNB has a Current Ratio of 1.82. This is a normal value and indicates that GRNB is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.82, GRNB is in line with its industry, outperforming 54.22% of the companies in the same industry.
GRNB has a Quick Ratio of 1.11. This is a normal value and indicates that GRNB is financially healthy and should not expect problems in meeting its short term obligations.
GRNB has a Quick ratio of 1.11. This is comparable to the rest of the industry: GRNB outperforms 53.01% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.11
GRNB Yearly Current Assets VS Current LiabilitesGRNB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

3

3. Growth

3.1 Past

GRNB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.52%.
GRNB shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.63% yearly.
The Revenue has decreased by -5.57% in the past year.
GRNB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.17% yearly.
EPS 1Y (TTM)-19.52%
EPS 3Y46.69%
EPS 5Y3.63%
EPS Q2Q%-5.33%
Revenue 1Y (TTM)-5.57%
Revenue growth 3Y11.46%
Revenue growth 5Y5.17%
Sales Q2Q%-4.25%

3.2 Future

GRNB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.57% yearly.
Based on estimates for the next years, GRNB will show a small growth in Revenue. The Revenue will grow by 2.41% on average per year.
EPS Next Y18.07%
EPS Next 2Y13.1%
EPS Next 3Y12.8%
EPS Next 5Y11.57%
Revenue Next Year-4.7%
Revenue Next 2Y-0.7%
Revenue Next 3Y0.65%
Revenue Next 5Y2.41%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GRNB Yearly Revenue VS EstimatesGRNB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10B 20B 30B
GRNB Yearly EPS VS EstimatesGRNB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.55, the valuation of GRNB can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of GRNB indicates a somewhat cheap valuation: GRNB is cheaper than 75.90% of the companies listed in the same industry.
GRNB's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.63.
A Price/Forward Earnings ratio of 6.47 indicates a rather cheap valuation of GRNB.
GRNB's Price/Forward Earnings ratio is rather cheap when compared to the industry. GRNB is cheaper than 80.72% of the companies in the same industry.
GRNB is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.55
Fwd PE 6.47
GRNB Price Earnings VS Forward Price EarningsGRNB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GRNB is valued a bit cheaper than 79.52% of the companies in the same industry.
GRNB's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. GRNB is cheaper than 79.52% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.54
EV/EBITDA 3.67
GRNB Per share dataGRNB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of GRNB may justify a higher PE ratio.
A more expensive valuation may be justified as GRNB's earnings are expected to grow with 12.80% in the coming years.
PEG (NY)0.47
PEG (5Y)2.36
EPS Next 2Y13.1%
EPS Next 3Y12.8%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.02%, GRNB is a good candidate for dividend investing.
GRNB's Dividend Yield is comparable with the industry average which is at 4.03.
Compared to an average S&P500 Dividend Yield of 2.27, GRNB pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.02%

5.2 History

The dividend of GRNB is nicely growing with an annual growth rate of 7.12%!
GRNB has been paying a dividend for over 5 years, so it has already some track record.
The dividend of GRNB decreased in the last 3 years.
Dividend Growth(5Y)7.12%
Div Incr Years2
Div Non Decr Years2
GRNB Yearly Dividends per shareGRNB Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

GRNB pays out 50.00% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of GRNB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP50%
EPS Next 2Y13.1%
EPS Next 3Y12.8%
GRNB Yearly Income VS Free CF VS DividendGRNB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B
GRNB Dividend Payout.GRNB Dividend Payout, showing the Payout Ratio.GRNB Dividend Payout.PayoutRetained Earnings

VANECK GREEN BOND ETF

NYSEARCA:GRNB (2/21/2025, 8:24:30 PM)

23.947

+0.04 (+0.18%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)04-24 2025-04-24
Inst Owners40.02%
Inst Owner Change24.64%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap16.90B
Analysts75.71
Price Target26.71 (11.54%)
Short Float %0%
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield 4.02%
Yearly Dividend1.25
Dividend Growth(5Y)7.12%
DP50%
Div Incr Years2
Div Non Decr Years2
Ex-Date02-03 2025-02-03 (0.0825)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.68%
PT rev (3m)-3.03%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.68%
EPS NY rev (3m)-2.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE 8.55
Fwd PE 6.47
P/S 0.58
P/FCF 5.54
P/OCF 3.12
P/B 0.91
P/tB 1.24
EV/EBITDA 3.67
EPS(TTM)2.8
EY11.69%
EPS(NY)3.7
Fwd EY15.45%
FCF(TTM)4.32
FCFY18.06%
OCF(TTM)7.68
OCFY32.08%
SpS41.05
BVpS26.41
TBVpS19.32
PEG (NY)0.47
PEG (5Y)2.36
Profitability
Industry RankSector Rank
ROA 5.28%
ROE 10.77%
ROCE 12.25%
ROIC 9.29%
ROICexc 10.6%
ROICexgc 13.08%
OM 12.44%
PM (TTM) 6.93%
GM 29.25%
FCFM 10.53%
ROA(3y)5.54%
ROA(5y)4.82%
ROE(3y)11.67%
ROE(5y)10.63%
ROIC(3y)9.16%
ROIC(5y)8.51%
ROICexc(3y)10.41%
ROICexc(5y)9.64%
ROICexgc(3y)12.74%
ROICexgc(5y)11.9%
ROCE(3y)12.06%
ROCE(5y)11.19%
ROICexcg growth 3Y13.26%
ROICexcg growth 5Y0.75%
ROICexc growth 3Y14.02%
ROICexc growth 5Y1.17%
OM growth 3Y10.53%
OM growth 5Y-0.4%
PM growth 3Y31.62%
PM growth 5Y-1.53%
GM growth 3Y0.15%
GM growth 5Y-1.05%
F-Score6
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.88
Debt/EBITDA 1.31
Cap/Depr 116.24%
Cap/Sales 8.18%
Interest Coverage 10.15
Cash Conversion 96.06%
Profit Quality 152.03%
Current Ratio 1.82
Quick Ratio 1.11
Altman-Z 2.43
F-Score6
WACC6.6%
ROIC/WACC1.41
Cap/Depr(3y)109.9%
Cap/Depr(5y)100.41%
Cap/Sales(3y)7.51%
Cap/Sales(5y)7.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.52%
EPS 3Y46.69%
EPS 5Y3.63%
EPS Q2Q%-5.33%
EPS Next Y18.07%
EPS Next 2Y13.1%
EPS Next 3Y12.8%
EPS Next 5Y11.57%
Revenue 1Y (TTM)-5.57%
Revenue growth 3Y11.46%
Revenue growth 5Y5.17%
Sales Q2Q%-4.25%
Revenue Next Year-4.7%
Revenue Next 2Y-0.7%
Revenue Next 3Y0.65%
Revenue Next 5Y2.41%
EBIT growth 1Y2.68%
EBIT growth 3Y23.2%
EBIT growth 5Y4.75%
EBIT Next Year61.62%
EBIT Next 3Y21.75%
EBIT Next 5Y16.53%
FCF growth 1Y7589.47%
FCF growth 3Y12.46%
FCF growth 5Y21.28%
OCF growth 1Y171.92%
OCF growth 3Y16.24%
OCF growth 5Y13.31%